NBY - NovaBay Pharmaceuticals Inc. (NBY) CEO Justin Hall on Q1 2022 Results - Earnings Call Transcript
NovaBay Pharmaceuticals, Inc. (NBY) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Jody Cain - LHA Investor Relations Justin Hall - Chief Executive Officer and General Counsel Andy Jones - Chief Financial Officer Conference Call Participants Destiny Hance - Ladenburg Thalmann Edward Woo - Ascendiant Capital Markets Presentation Operator Good afternoon and welcome to NovaBay Pharmaceuticals First Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Jody Cain. Please go ahead, ma'am. Jody Cain This is Jody Cain with LHA. Thank you for participating in today’s call. Joining me from NovaBay are Justin Hall, Chief Executive Officer and General Counsel; and Andy Jones, the company’s Chief Financial Officer. I
For further details see:
NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q1 2022 Results - Earnings Call Transcript